# FDA Inspection 920186 - Attalla, Ashraf, M.D. - March 12, 2015

Source: https://www.keypedia.com/records/fda_inspections/attalla-ashraf-md/a29f2070-59b3-4753-9873-3fe0e4dc22fa
Source feed: FDA_Inspections

> FDA Inspection 920186 for Attalla, Ashraf, M.D. on March 12, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 920186
- Company Name: Attalla, Ashraf, M.D.
- Inspection Date: 2015-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 790951 - 2012-07-13](https://www.keypedia.com/records/fda_inspections/attalla-ashraf-md/0abdf20e-93df-4d3b-bd99-99eeb5e86769)
- [FDA Inspection 597613 - 2009-07-13](https://www.keypedia.com/records/fda_inspections/attalla-ashraf-md/edb40548-9650-4ba4-ba4a-7fffe719137b)

Company: https://www.keypedia.com/companies/attalla-ashraf-md/3a23b999-cd51-4abd-85e6-b71acbac20ac

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c